The study enrolled 25 patients with high-grade bladder cancer that had come back after earlier BCG treatment. Their median ...
A new review explains why BCG immunotherapy fails in some bladder cancer patients and outlines emerging combination ...
Anktiva is now approved for BCG-unresponsive papillary-only bladder cancer. Here’s what the bladder-sparing option involves, ...
Bladder-sparing options for BCG-unresponsive non-muscle invasive bladder cancer have transformed since 2020, according to Saum Ghodoussipour, MD. The treatment paradigm for non–muscle-invasive bladder ...
Mens Fitness on MSN
New FDA approval aims to help patients avoid bladder removal surgery
The decision gives certain patients whose cancer has resisted BCG therapy another treatment option aimed at preserving the ...
In May 2025, the first human bladder transplant was performed at UCLA Health. One year later, the patient is thriving. A second patient has received a successful bladder transplant. Two more patients ...
Despite its increasing prevalence, a painful condition called bladder pain syndrome, or interstitial cystitis, remains understudied with limited treatment options. In an eNeuro paper, Min-Zhi Su and ...
The vast majority of Australia's bladder cancer cases are in men, but experts are concerned about the number of women ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results